Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Strober, I. Fuss, Kazuhiko Nakamura, A. Kitani (2003)
Recent advances in the understanding of the induction and regulation of mucosal inflammation.Journal of gastroenterology, 38 Suppl 15
M. Fromm (2002)
Genetically determined differences in P-glycoprotein function: implications for disease risk.Toxicology, 181-182
B. Hendrickson, R. Gokhale, Judy Cho (2002)
Clinical Aspects and Pathophysiology of Inflammatory Bowel DiseaseClinical Microbiology Reviews, 15
J. Kiernan (1981)
Histological and Histochemical Methods: Theory and Practice
S. Resta-Lenert, K. Barrett (2003)
Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)Gut, 52
L. Maggio‐Price, D. Shows, K. Waggie, A. Burich, Weiping Zeng, S. Escobar, P. Morrissey, J. Viney (2002)
Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.The American journal of pathology, 160 2
G. Bouma, W. Strober (2003)
The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 3
A. Bhan, Emiko Mizoguthi, R. Smith, A. Mizoguchi (1999)
Colitis in transgenic and knockout animals as models of human inflammatory bowel diseaseImmunological Reviews, 169
B. Yacyshyn, W. Maksymowych, M. Bowen-Yacyshyn (1999)
Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis.Human immunology, 60 8
F. Pallone, G. Blanco, P. Vavassori, I. Monteleone, D. Fina, G. Monteleone (2003)
Genetic and pathogenetic insights into inflammatory bowel diseaseCurrent Gastroenterology Reports, 5
A. Gewirtz, A. Neish, J. Madara (2002)
Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins.Advances in experimental medicine and biology, 507
A. Stadnicki, R. Colman (2003)
Experimental models of inflammatory bowel disease.Archivum immunologiae et therapiae experimentalis, 51 3
R. Boismenu, Yaping Chen (2000)
Insights from mouse models of colitisJournal of Leukocyte Biology, 67
C. Elson, Y. Cong (2002)
Understanding immune-microbial homeostasis in intestineImmunologic Research, 26
T. Hove, P. Drillenburg, J. Wijnholds, A. Velde, S. Deventer (2002)
Differential Susceptibility of Multidrug Resistance Protein-1 Deficient Mice to DSS and TNBS-Induced ColitisDigestive Diseases and Sciences, 47
T. Hibi, H. Ogata, A. Sakuraba (2002)
Animal models of inflammatory bowel diseaseJournal of Gastroenterology, 37
W. Sandborn, W. Faubion (2000)
Clinical pharmacology of inflammatory bowel disease therapiesCurrent Gastroenterology Reports, 2
Theodore Saclarides, S. Jakate, John Coon, Achyut Bhattacharyya, Jose Dominguez, D. Szeluga, Ronald Weinstein (1992)
Variable expression of P-glycoprotein in normal, inflamed, and dysplastic areas in ulcerative colitisDiseases of the Colon & Rectum, 35
S. Resta-Lenert, J. Smitham, K. Barrett (2003)
Natural history of colitis and associated epithelial dysfunction in conventionally housed Mdrla-/-miceGastroenterology, 124
S. Resta-Lenert, K. Barrett (2002)
Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2.Gastroenterology, 122 4
G. Ho, Moodie Fm, J. Satsangi (2003)
Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?Gut, 52
R. Farrell, D. Kelleher (2003)
Glucocorticoid resistance in inflammatory bowel disease.The Journal of endocrinology, 178 3
T. Pizarro, K. Arseneau, G. Bamias, F. Cominelli (2003)
Mouse models for the study of Crohn's disease.Trends in molecular medicine, 9 5
M. Murphy, E. Eastham, R. Nelson, A Pearson, M Laker (1989)
Intestinal permeability in Crohn's disease.Archives of Disease in Childhood, 64
J. Meddings (1997)
Review article: Intestinal permeability in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 11
F. Heller, R. Duchmann (2003)
Intestinal flora and mucosal immune responses.International journal of medical microbiology : IJMM, 293 1
H. Iizasa, Naomi Genda, Tomohide Kitano, M. Tomita, K. Nishihara, M. Hayashi, Kayako Nakamura, Shizuko Kobayashi, E. Nakashima (2003)
Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice.Journal of pharmaceutical sciences, 92 3
F. Guarner, F. Casellas, N. Borruel, M. Antolín, S. Videla, J. Vilaseca, J. Malagelada (2002)
Role of microecology in chronic inflammatory bowel diseasesEuropean Journal of Clinical Nutrition, 56
M. Schwab, E. Schaeffeler, Claudia Marx, M. Fromm, B. Kaskas, J. Metzler, E. Stange, H. Herfarth, J. Schoelmerich, M. Gregor, S. Walker, I. Cascorbi, I. Roots, U. Brinkmann, U. Zanger, M. Eichelbaum (2003)
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.Gastroenterology, 124 1
C. Panwala, Jon Jones, J. Viney (1998)
A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis.Journal of immunology, 161 10
P-glycoprotein, the product of the multidrug resistance protein 1 (MDR1) gene, is a xenobiotic transporter that may contribute to the physiology of the intestinal barrier. Twenty-five percent of mdr1a -deficient (mdr1a –/– ) mice spontaneously develop colitis at variable ages when maintained under specific pathogen-free conditions. We hypothesized that this disease would result from epithelial dysfunction and that conventional housing would increase incidence and severity of the colitis phenotype. Wild-type congenic FVB (+/+) mice were maintained under the same conditions as controls. Knockout and wild-type mice were matched for age and gender and observed for signs of colitis. Colonic tissues from both groups of mice were examined for macroscopic and microscopic injury and for basal ion transport and transepithelial resistance (TER). Translocation of bacteria across the intestine was assessed by culturing the spleen and mesenteric lymph nodes. Protein analysis was performed by Western blot analysis. All mdr1a –/– mice developed weight loss and signs of colitis, whereas wild-type mice never showed such signs. Within the mdr1a –/– group, males consistently developed severe colitis earlier than females. Knockout mice showed increased basal colonic ion transport (females, 162.7 ± 4.6 vs. 49.7 ± 3.8 µA/cm 2 ; males, 172.6 ± 5.6 vs. 54.2 ± 3.1 µA/cm 2 ; P < 0.01) and decreased TER (females, 25.4 ± 0.3 vs. 36.4 ± 0.8 Ω·cm 2 ; males, 23.1 ± 1.0 vs . 38.3 ± 0.2 Ω·cm 2 ; P < 0.01) compared with wild-type mice. Barrier dysfunction was accompanied by decreased phosphorylation of tight junction proteins. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in intestinal tissues was increased in the mdr1a –/– group ( P < 0.01) and correlated with disease severity. Bacterial translocation was greater both in incidence ( P < 0.01) and severity ( P < 0.001) for the knockout group. With respect to all indexes studied, mdr1a –/– males performed worse than females. Our data support the hypothesis that alterations in the intestinal barrier alone, in the absence of immune dysfunction, may rapidly lead to colitis in the setting of a normal colonic flora. animal models; gender differences; barrier function Address for reprint requests and other correspondence: S. Resta-Lenert, UCSD Medical Center 8414, 200 West Arbor Drive, San Diego, CA 92103 (E-mail: [email protected] )
AJP - Gastrointestinal and Liver Physiology – The American Physiological Society
Published: Jul 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.